Veradigm | Nettoeinkommen

Aktienkurs
4.30
Täglich Wechseln
-0.20 -4.44%
Monatlich
-9.47%
Jährlich
-19.63%
Q1 Prognose
7.75




Nettoeinkommen Veränderung Datum
Alcidion AUD 2.54M 3.43M 2025-06
Ambu A/S DKK 118M 3M 2025-12
Amplifon EUR 6.3M 28.94M 2025-09
Cardinal Health USD 467M 17M 2025-12
Centene USD -1.1B 5.53B 2025-12
Charles River Laboratories USD 54.42M 2.1M 2025-09
Cigna USD 1.23B 55.22B 2025-12
Convatec Group USD 111.9M 72.6M 2024-12
CVS Health USD 2.94B 6.92B 2025-12
Diasorin EUR 38.26M 9.14M 2025-09
Elevance Health USD 547M 642M 2025-12
General Electric Aerospace USD 2.54B 384M 2025-12
Gulf Medical Proj AED 34.98M 12.51M 2025-06
Humana USD -796M 991M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 261.1M 23.2M 2025-09
Maximus USD 75.29M 30.69M 2025-09
McKesson USD 1.19B 76M 2025-12
Med Life RON 7.24M 23.18M 2025-09
Molina Healthcare USD -160M 239M 2025-12
Omnicell USD -2.03M 7.49M 2025-12
Oriola-kd EUR 1.7M 7.3M 2025-09
Owens Minor USD -24.98M 271.13M 2025-03
Quest Diagnostics USD 245M 0 2025-12
Rede D'or Sao Luiz BRL 1.47B 472.3M 2025-09
Siemens Healthineers EUR 449M 139M 2025-12
Sonova Holding CHF 188.5M 143.4M 2025-12
Supermax Corporation Bhd MYR -134.61M 67.57M 2025-09
UnitedHealth USD 10M 2.34B 2025-12
Veeva Systems USD 200.31M 27.88M 2025-06
Veradigm USD 14.53M 78.55M 2022-09
Xerox USD -109M 19M 2025-06


Veradigm Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.